hc1 is a biotechnology, healthcare, and internet startup headquartered in the United States. Founded in 2011, the company's slogan "Transforming lab data into personalized healthcare insights.®" highlights its focus on leveraging data to improve healthcare outcomes. The company's flagship solutions, hc1 Performance Analytics™ and hc1 Operations Management™, have enabled hc1 to establish partnerships across the lab and health system space, emphasizing its commitment to increasing efficiency and reducing costs through actionable insights. In April 2019, hc1 secured a noteworthy $2.50M Venture Round investment, signaling investor confidence in its innovative offerings. The company's core product, the hc1 Lab Insights Platform™, processes an impressive 30 billion clinical transactions and 500 million test results per month, catering to the needs of high-volume healthcare organizations. Additionally, the company's dedication to security is evident through its HITRUST CSF® v9.3 Risk-based, 2-year (r2) certification, underscoring its commitment to data protection and compliance. With a mission focused on "Right Patient. Right Test. Right Prescription," hc1 is continuously developing new solutions, such as hc1 PrecisionDx Advisor™ and hc1 Workforce Optimization™, aimed at improving patient care and advancing its position as a leader in identifying real-time insights and risk signals from laboratory data.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $2.50M | - | 10 Apr 2019 | |
Series B | $7.00M | 2 | Health Cloud Capital | 10 Apr 2018 |
Venture Round | $1.50M | - | 18 Jul 2017 | |
Venture Round | $13.20M | - | 21 Oct 2015 | |
Debt Financing | $5.00M | 1 | SCM Specialty Finance Opportunities Fund | 21 Oct 2015 |
No recent news or press coverage available for hc1.